Mendeley

J’utilisais jusqu’à présent avec délice Papers, de mekentosj.com pour stocker, lire et archiver mes lectures académiques. Se points forts étaient:

• l’ergonomie de son interface, quasi parfaite (un vrai iTunes pour .pdf)
• la capacité à indexer directement depuis un .pdf via pubmed ou google scholar
• et petit délice, l’application iPhone qui permettait de récupérer à la volée en congrès des référence bibliographiques.

N’ayant plus d’iPhone ce dernier avantage à disparu et m’a laissé entrevoir quelques lacune :

• pas de synchronisation internet, obligeant à maintenir en parallèle un compte CiteULike (également une réussite, surtout depuis le développement des fonctions de suggestion, réellement pertinentes)
• pas d’interface avec word (Latex ou même de Pages’09 étant si peu répandus dans notre spécialité que le choix n’existe pas…), obligeant à maintenir diverses bibliographies sur EndNote en parallèle (qui pour le coup n’est pas un merveille…)
• et une gestion des tags assez obscure, voire pire…

Je suis tombé il y a quelques jours sur Mendeley, qui semble combler toutes ses lacunes, même si pour le coup l’interface et l’expérience utilisateur reste bien en dessous du logiciel de mekentosj. Il ne me reste plus qu’à relever le défis du transfert de tous les papiers de droite et de gauche, et je pourrais enfin dire s’il s’agit de la merveille promise…

PubMed – Le renouveau

Gaetan du blogue CISMeF, nous dévoile la nouvelle interface PubMed : http://preview.ncbi.nlm.nih.gov/pubmed

Chouette!

Audio From SFAR 2009

4 petits fichiers audio de 4 conférences du congrès SFAR 2009.

• Cas Clinique Hémorragie du Post-Partum
• Le “damage control surgery”
• Pandémie de grippe A(H1N1)v : l’expérience australienne
• Pandémie de grippe A(H1N1)v : Le point de vue d’un médecin de santé publique

Note : Ces conférences étaient destinées a un public médical exclusivement. Il ne s’agit pas d’une information pour le grand public.

Note 2 : Si vous êtes l’auteur d’une de ces conférence et que vous ne souhaitez pas que votre intervention soit publiée, contactez-moi par mail : ajoutez @gmail.com après pm.bertrand

Caffeine

Equivalence des taux de cafféine via http://www.informationisbeautiful.net

Auto-remplissage PubMed

Auto-Remplissage PubMed

PubMed propose une fonction d’auto-remplissage du champs de recherche ma fois fort pratique… Je ne sais pas depuis combien de temps, mais c’est la première fois que je le vois. Au fait, le moteur de recherche PubMed pour Firefox existe-t-il encore?

Réponse: Oui, il s’est même ajouté spontanément lorsque j’ai cliqué sur mes moteurs de recherche depuis PubMed…

Suivi des lectures

J’imprime encore beaucoup d’articles que je dois lire. Et il faut bien dire que cela fout un beau bordel dans mes classements. Il n’est en effet pas rare que je trimbale une dizaine d’article et que certains restent dans mon classeur plusieurs semaines avant d’être digérés. En assurer le suivi était assez complexe jusqu’à présent. Entre les papiers non lu et classés puis oubliés (dans Papers® ou dans EndNote® en fonction…) et les papiers lus, mais rapidement perdus car finalement classés nul part, j’en au eu assez.

J’ai donc fait ce petit .pdf que j’agrafe au début de toutes mes impressions

Morphine

DSC09126

Mise en ligne par Oh Lenna

On est pas les seuls…

Ruralization of health professional education in the UK faces substantial challenges. More may need to be done to increase recruitment of rural-interested students, foster rural career interest during courses, recruit rural role models, develop rural curricula and establish the infrastructure to support rural clinical placements. These initiatives will require greater political will and some investment by education, heath and community development agencies.

Perceptions of UK medical students on rural clinical placements. Deaville JA, Wynn-Jones J, Hays RB, Coventry PJ, McKinley RK, Randall-Smith J. Rural Remote Health. 2009 Apr-Jun;9(2):1165. Epub 2009 Jun 2

Lectures Hors-Série “ventilator-associated pneumonia AND acute respiratory distress syndrome”

• Zaydfudim, V., L. A. Dossett, et al. (2009). “Implementation of a real-time compliance dashboard to help reduce SICU ventilator-associated pneumonia with the ventilator bundle.” Archives of surgery (Chicago, Ill : 1960) 144(7): 656-62.
• Zambon, M. and J. L. Vincent (2008). “Mortality rates for patients with acute lung injury/ARDS have decreased over time.” Chest 133(5): 1120-7.
• Zahar, J. R., M. Nguile-Makao, et al. (2009). “Predicting the risk of documented ventilator-associated pneumonia for benchmarking: Construction and validation of a score.” Crit Care Med.
• Vidaur, L., B. Gualis, et al. (2005). “Clinical resolution in patients with suspicion of ventilator-associated pneumonia: a cohort study comparing patients with and without acute respiratory distress syndrome.” Crit Care Med 33(6): 1248-1253.
• Valencia, M. and A. Torres (2009). “Ventilator-associated pneumonia.” Curr Opin Crit Care 15(1): 30-5.
• Trouillet, J. L., A. Vuagnat, et al. (2002). “Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms.” Clin Infect Dis 34(8): 1047-54.
• Trouillet, J. L., J. Chastre, et al. (1998). “Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.” Am J Respir Crit Care Med 157(2): 531-9.
• Trouillet, J. L. (2009). QFP – Pneumopathie acquise sous ventilation mécanique. Miscellaneous.
• Torres, A., S. Ewig, et al. (2009). “Defining, treating and preventing hospital acquired pneumonia: European perspective.” Intensive Care Medicine 35(1): 9-29.
• Tolentino-DelosReyes, A. F., S. D. Ruppert, et al. (2007). “Evidence-based practice: use of the ventilator bundle to prevent ventilator-associated pneumonia.” Am J Crit Care 16(1): 20-7.
• Society, A. T. and I. D. S. o. America (2005). “Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.” Am J Respir Crit Care Med 171(4): 388-416.
• Shorr, A. F., A. Combes, et al. (2006). “Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy.” Crit Care Med 34(3): 700-6.
• Seidenfeld, J. J., D. F. Pohl, et al. (1986). “Incidence, site, and outcome of infections in patients with the adult respiratory distress syndrome.” Am Rev Respir Dis 134(1): 12-6.
• Rotstein, C., G. Evans, et al. (2008). “Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults.” Can J Infect Dis Med Microbiol 19(1): 19-53.
• Robert, R., G. Grollier, et al. (2003). “Colonization of lower respiratory tract with anaerobic bacteria in mechanically ventilated patients.” Intensive Care Med 29(7): 1062-1068.
• Ramírez, P., M. Ferrer, et al. (2009). “Systemic inflammatory response and increased risk for ventilator-associated pneumonia: a preliminary study.” Crit Care Med 37(5): 1691-5.
• Protti, A., D. Chiumello, et al. (2009). “Relationship between gas exchange response to prone position and lung recruitability during acute respiratory failure.” Intensive Care Med 35(6): 1011-7.
• Pingleton, S. K., J. Y. Fagon, et al. (1992). “Patient selection for clinical investigation of ventilator-associated pneumonia. Criteria for evaluating diagnostic techniques.” Chest 102(5 Suppl 1): 553S-556S.
• Phua, J., T. E. Stewart, et al. (2008). “Acute respiratory distress syndrome 40 years later: time to revisit its definition.” Crit Care Med 36(10): 2912-2921.
• Phua, J., J. R. Badia, et al. (2009). “Has mortality from acute respiratory distress syndrome decreased over time?: A systematic review.” Am J Respir Crit Care Med 179(3): 220-227.
• Petrucci, N. and W. Iacovelli (2007). “Lung protective ventilation strategy for the acute respiratory distress syndrome.” Cochrane Database Syst Rev(3): CD003844.
• Panchabhai, T. S., N. S. Dangayach, et al. (2009). “Oropharyngeal cleansing with 0.2% chlorhexidine for prevention of nosocomial pneumonia in critically ill patients: an open-label randomized trial with 0.01% potassium permanganate as control.” Chest 135(5): 1150-6.
• Nieszkowska, A., Q. Lu, et al. (2004). “Incidence and regional distribution of lung overinflation during mechanical ventilation with positive end-expiratory pressure.” Crit Care Med 32(7): 1496-503.
• Morris, A. C., K. Kefala, et al. (2009). “Evaluation of the effect of diagnostic methodology on the reported incidence of ventilator-associated pneumonia.” Thorax 64(6): 516-22.
• Michaud, S., S. Suzuki, et al. (2002). “Effect of design-related bias in studies of diagnostic tests for ventilator-associated pneumonia.” Am J Respir Crit Care Med 166(10): 1320-5.
• Mercat, A., J. C. Richard, et al. (2008). “Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial.” JAMA 299(6): 646-55.
• Meduri, G. U., R. C. Reddy, et al. (1998). “Pneumonia in acute respiratory distress syndrome. A prospective evaluation of bilateral bronchoscopic sampling.” Am J Respir Crit Care Med 158(3): 870-875.
• Meduri, G. U., G. L. Mauldin, et al. (1994). “Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia.” Chest 106(1): 221-35.
• Meduri, G. U. and J. Chastre (1992). “The standardization of bronchoscopic techniques for ventilator-associated pneumonia.” Chest 102(5 Suppl 1): 557S-564S.
• Meduri, G. U. (2002). “Clinical review: a paradigm shift: the bidirectional effect of inflammation on bacterial growth. Clinical implications for patients with acute respiratory distress syndrome.” Crit Care 6(1): 24-9.
• Markowicz, P., M. Wolff, et al. (2000). “Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome. Incidence, prognosis, and risk factors. ARDS Study Group.” Am J Respir Crit Care Med 161(6): 1942-1948.
• Magnotti, L. J., T. J. Schroeppel, et al. (2009). “Efficacy of monotherapy in the treatment of Pseudomonas ventilator-associated pneumonia in patients with trauma.” The Journal of trauma 66(4): 1052-8; discussion 1058-9.
• Luyt, C. E., V. Guerin, et al. (2005). “Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia.” Am J Respir Crit Care Med 171(1): 48-53.
• Luyt, C. E., A. Combes, et al. (2008). “Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia.” Intensive Care Med 34(8): 1434-40.
• Luyt, C. E., A. Combes, et al. (2009). “Aerosolized antibiotics to treat ventilator-associated pneumonia.” Curr Opin Infect Dis 22(2): 154-8.
• Luyt, C. E., J. Chastre, et al. (2004). “Value of the clinical pulmonary infection score for the identification and management of ventilator-associated pneumonia.” Intensive Care Med 30(5): 844-52.
• Lisboa, T., E. Diaz, et al. (2008). “The ventilator-associated pneumonia PIRO score: a tool for predicting ICU mortality and health-care resources use in ventilator-associated pneumonia.” Chest 134(6): 1208-1216.
• Linden, V. B., M. K. Lidegran, et al. (2009). “ECMO in ARDS: a long-term follow-up study regarding pulmonary morphology and function and health-related quality of life.” Acta Anaesthesiol Scand 53(4): 489-95.
• Lemaire, F. and F. Jardin (2005). “Quelle(s) définition(s) pour le syndrome de détresse respiratoire aiguë ?” Réanimation 14(5): 333-335.
• Kollef, M., D. Pittet, et al. (2006). “A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia.” Am J Respir Crit Care Med 173(1): 91-7.
• Jung, B., M. Sebbane, et al. (2007). “[Ventilator-associated pneumonia: follow the guidelines!].” Ann Fr Anesth Reanim 26(10): 844-9.
• Hilbert, G., D. Gruson, et al. (1997). “Sequential use of noninvasive pressure support ventilation for acute exacerbations of COPD.” Intensive Care Med 23(9): 955-61.
• Hayon, J., C. Figliolini, et al. (2002). “Role of serial routine microbiologic culture results in the initial management of ventilator-associated pneumonia.” Am J Respir Crit Care Med 165(1): 41-6.
• Guerin, C., S. Gaillard, et al. (2004). “Effects of systematic prone positioning in hypoxemic acute respiratory failure: a randomized controlled trial.” JAMA 292(19): 2379-87.
• Gruson, D., G. Hilbert, et al. (1998). “Sequential production of leukaemia inhibitory factor by blood cell culture in patients with ARDS.” Intensive Care Med 24(4): 366-8.
• Goldstein, I., J. Chastre, et al. (2006). “Novel and innovative strategies to treat ventilator-associated pneumonia: optimizing the duration of therapy and nebulizing antimicrobial agents.” Semin Respir Crit Care Med 27(1): 82-91.
• Geerts, L., P. G. Jorens, et al. (2001). “Natural inhibitors of neutrophil function in acute respiratory distress syndrome.” Critical Care Medicine 29(10): 1920-4.
• Gattinoni, L., P. Caironi, et al. (2006). “Lung recruitment in patients with the acute respiratory distress syndrome.” N Engl J Med 354(17): 1775-86.
• Frank, J. A., P. E. Parsons, et al. (2006). “Pathogenetic significance of biological markers of ventilator-associated lung injury in experimental and clinical studies.” Chest 130(6): 1906-14.
• Fagon, J. Y., J. Chastre, et al. (2000). “Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial.” Ann Intern Med 132(8): 621-30.
• Fagon, J. Y., J. Chastre, et al. (2007). “Is bronchoalveolar lavage with quantitative cultures a useful tool for diagnosing ventilator-associated pneumonia?” Crit Care 11(2): 123.
• Fagon, J. Y., J. Chastre, et al. (1996). “Mortality due to ventilator-associated pneumonia or colonization with Pseudomonas or Acinetobacter species: assessment by quantitative culture of samples obtained by a protected specimen brush.” Clin Infect Dis 23(3): 538-42.
• Fagon, J. Y. and J. Chastre (2003). “Diagnosis and treatment of nosocomial pneumonia in ALI/ARDS patients.” Eur Respir J Suppl 42: 77s-83s.
• Fagon, J. Y. and J. Chastre (2000). “Management of Suspected Ventilator-Associated Pneumonia.” Ann Intern Med 133(12): 1009.
• Esteban, A., P. Fernández-Segoviano, et al. (2004). “Comparison of clinical criteria for the acute respiratory distress syndrome with autopsy findings.” Ann Intern Med 141(6): 440-5.
• Delclaux, C., E. Roupie, et al. (1997). “Lower respiratory tract colonization and infection during severe acute respiratory distress syndrome: incidence and diagnosis.” Am J Respir Crit Care Med 156(4 Pt 1): 1092-1098.
• Croce, M. A., T. C. Fabian, et al. (1995). “Using bronchoalveolar lavage to distinguish nosocomial pneumonia from systemic inflammatory response syndrome: a prospective analysis.” J Trauma 39(6): 1134-9; discussion 1139-40.
• Croce, M. A. (2000). “Diagnosis of acute respiratory distress syndrome and differentiation from ventilator-associated pneumonia.” Am J Surg 179(2A Suppl): 26S-29S; discussion 30S.
• Craven, D. E., A. Chroneou, et al. (2009). “Ventilator-associated tracheobronchitis: the impact of targeted antibiotic therapy on patient outcomes.” Chest 135(2): 521-8.
• Combes, A., C. E. Luyt, et al. (2004). “Impact of methicillin resistance on outcome of Staphylococcus aureus ventilator-associated pneumonia.” Am J Respir Crit Care Med 170(7): 786-92.
• Combes, A., C. E. Luyt, et al. (2007). “Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia.” Crit Care Med 35(1): 146-54.
• Combes, A., C. E. Luyt, et al. (2006). “Impact of piperacillin resistance on the outcome of Pseudomonas ventilator-associated pneumonia.” Intensive Care Med 32(12): 1970-8.
• Combes, A., C. Figliolini, et al. (2002). “Incidence and outcome of polymicrobial ventilator-associated pneumonia.” Chest 121(5): 1618-23.
• Combes, A., C. Figliolini, et al. (2003). “Factors predicting ventilator-associated pneumonia recurrence.” Crit Care Med 31(4): 1102-7.
• Cochrane, C. G., R. G. Spragg, et al. (1983). “The presence of neutrophil elastase and evidence of oxidation activity in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome.” Am Rev Respir Dis 127(2): S25-7.
• Chiumello, D., E. Carlesso, et al. (2008). “Lung stress and strain during mechanical ventilation for acute respiratory distress syndrome.” Am J Respir Crit Care Med 178(4): 346-55.
• Chien, J., P. Hsueh, et al. (2009). “The evolution of drug-resistant microorganisms in patients with prolonged mechanical ventilation.” American Journal of Infection Control 37(3): 231-6.
• Chastre, J., R. Wunderink, et al. (2008). “Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study.” Crit Care Med 36(4): 1089-96.
• Chastre, J., M. Wolff, et al. (2003). “Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.” JAMA 290(19): 2588-98.
• Chastre, J., J. L. Trouillet, et al. (1998). “Nosocomial pneumonia in patients with acute respiratory distress syndrome.” Am J Respir Crit Care Med 157(4 Pt 1): 1165-72.
• Chastre, J., C. E. Luyt, et al. (2006). “New diagnostic and prognostic markers of ventilator-associated pneumonia.” Curr Opin Crit Care 12(5): 446-51.
• Chastre, J., C. E. Luyt, et al. (2006). “Use of quantitative cultures and reduced duration of antibiotic regimens for patients with ventilator-associated pneumonia to decrease resistance in the intensive care unit.” Clin Infect Dis 43 Suppl 2: S75-81.
• Chastre, J. and J. Y. Fagon (2007). “Diagnosis of ventilator-associated pneumonia.” N Engl J Med 356(14): 1469; author reply 1470-1.
• Chastre, J. and J. Y. Fagon (2002). “Ventilator-associated pneumonia.” Am J Respir Crit Care Med 165(7): 867-903.
• Chastre, J., A. Combes, et al. (2005). “The invasive (quantitative) diagnosis of ventilator-associated pneumonia.” Respir Care 50(6): 797-807; discussion 807-12.
• Chastre, J. (2008). “Preventing ventilator-associated pneumonia: could silver-coated endotracheal tubes be the answer?” JAMA 300(7): 842-4.
• Chastre, J. (2006). “Ventilator-associated pneumonia: what is new?” Surg Infect (Larchmt) 7 Suppl 2: S81-5.
• Chastre, J. (2005). “Conference summary: ventilator-associated pneumonia.” Respir Care 50(7): 975-83.
• Chastre, J. (2005). “Antibiotic prescribing for ventilator-associated pneumonia: get it right from the beginning but be able to rapidly deescalate.” Intensive Care Med 31(11): 1463-5.
• Bernard, G. R., A. Artigas, et al. (1994). “The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.” Am J Respir Crit Care Med 149(3 Pt 1): 818-24.
• Bell, R. C., J. J. Coalson, et al. (1983). “Multiple organ system failure and infection in adult respiratory distress syndrome.” Ann Intern Med 99(3): 293-8.
• Bauer, T. T., M. Valencia, et al. (2005). “Respiratory microbiology patterns within the first 24 h of ARDS diagnosis: influence on outcome.” Chest 128(1): 273-9.
• Andrews, C. P., J. J. Coalson, et al. (1981). “Diagnosis of nosocomial bacterial pneumonia in acute, diffuse lung injury.” Chest 80(3): 254-8.
• Anand, N. J., S. Zuick, et al. (2009). “Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU.” Chest 135(3): 641-7.
• American Thoracic Society and I. D. S. o. America (2005). “Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.” Am J Respir Crit Care Med 171(4): 388-416.

Street Anatomy

Mise en ligne par lucamaleonte